Metformin Plus Tyrosine Kinase Inhibitors for Treatment of Patients With Non-small Cell Lung Cancer With EGFR Mutations
Clinical trial NCT05445791 · RECRUITING
Trial details
- NCT number
- NCT05445791
- Sponsor
- Instituto Nacional de Cancerologia de Mexico
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-15
- Primary completion
- 2026-07-14
- Enrollment
- 312
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.